Scarica l'app Stockscreener
1.20
0.83%
-0.01
Dopo l'orario di chiusura:
1.18
-0.02
-1.67%
Precedente Chiudi:
$1.21
Aprire:
$1.21
Volume 24 ore:
55,516
Relative Volume:
0.83
Capitalizzazione di mercato:
$20.01M
Reddito:
$3.20M
Utile/perdita netta:
$-10.90M
Rapporto P/E:
-1.7809
EPS:
-0.6738
Flusso di cassa netto:
$-7.92M
1 W Prestazione:
-3.23%
1M Prestazione:
+4.35%
6M Prestazione:
-14.89%
1 anno Prestazione:
+31.98%
Intervallo 1D:
$1.18
$1.23
Intervallo di 1 settimana:
$1.18
$1.39
Portata 52W:
$0.84
$2.46
Marker Therapeutics Inc Stock (MRKR) Company Profile
Nome
Marker Therapeutics Inc
Settore
Industria
Telefono
(713) 400-6400
Indirizzo
2450 HOLCOMBE BLVD, HOUSTON, TX
Compare MRKR vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.20 | 20.17M | 3.20M | -10.90M | -7.92M | -0.6738 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-05 | Iniziato | Canaccord Genuity | Buy |
| 2021-03-25 | Iniziato | Piper Sandler | Overweight |
| 2021-03-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Iniziato | ROTH Capital | Buy |
| 2019-03-01 | Iniziato | Janney | Buy |
| 2018-12-03 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Marker Therapeutics Inc Borsa (MRKR) Ultime notizie
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight - Business Upturn
Marker Therapeutics (MRKR) Holds at $1.24 as Shares Trade Flat Within RangeVolume Spike Alerts - siam.in
Marker Therapeutics Inc. (MRKR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - webull.com
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com India
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy - Investing.com
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportIchimoku Kumo Twist - vinanet.vn
Marker Therapeutics Stock Price Forecast. Should You Buy MRKR? - StockInvest.us
Marker Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportVanna Flow - Vinanet
Marker Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CCORF Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Stock List: Research Stocks from Around the World - GuruFocus
Marker Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Marker Therapeutics Inc (MRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseProfit Inflection Point - vinanet.vn
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Investors Focus on Clinical MilestonesGuidance Downgrade Alert - vinanet.vn
Marker Therapeutics, Inc. Revenue Breakdown – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc (MRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Marker Therapeutics Inc (MRKR) Balance Sheet - TradingKey
Marker Therapeutics Inc (MRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Marker Therapeutics Inc (MRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Marker Therapeutics Inc (MRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.220|Chg%:-0.050 - TradingKey
Marker Therapeutics Inc (MRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
US High Growth Tech Stocks to Watch for Potential Expansion - simplywall.st
High Growth Tech Stocks In The US Market - simplywall.st
Exploring High Growth Tech Stocks In The US For July 2026 - simplywall.st
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress ContinuesGuidance Revision Trend - vinanet.vn
MRKR Q1 2026 Earnings: Narrower Loss Slightly Beats Expectations as Stock SlipsRevenue Warning Signal - vinanet.vn
Marker Therapeutics (MRKR) Slips 4.43% as Biotech Struggles, Holds Above $1.43 SupportBreakout Confirmation - dars.gov.et
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target By Investing.com - Investing.com Canada
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target - Investing.com
MSN Money - MSN
Marker Therapeutics, Inc.'s (NASDAQ:MRKR) Profit Outlook - simplywall.st
MRKR Q1 2026 Earnings: Narrower Loss Surpasses ExpectationsRevenue Growth Outlook - dars.gov.et
US High Growth Tech Stocks to Watch - simplywall.st
Marker Therapeutics Surges 11%: Key Levels and Potential Catalysts in FocusStandard Deviation - dars.gov.et
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Price to earnings forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc. (MRKR) Posts Modest Gain as Shares Approach Key ResistanceCash Flow Strong Stocks - dars.gov.et
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
MRKR Forecast — Price Target — Prediction for 2027 - TradingView
Marker Therapeutics, Inc. Actuals & Estimates (NASDAQ:MRKR) - TradingView
Price to sales forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Price to book forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc Azioni (MRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):